Welcome!

News Feed Item

Easton Pharmaceuticals Announces 2 Medical Marijuana Investment Proposals Which Include the Launch of Medical Marijuana Dispensary(s) in the State of Michigan and an Investment Into Medical Marijuana Technologies to Assist Growers With Harvests

TORONTO, ON -- (Marketwired) -- 06/06/14 -- Easton Pharmaceuticals Inc. -- (OTC: EAPH) -- announces it has received and is in late stage discussions with two investment proposals in the medical marijuana industry.

Easton Pharmaceuticals will be decided upon within the next week to 10 days which involves two proposals and investment opportunities in the medical marijuana industry. The first proposal stems from a signed LOI and discussions initiated with UMED Health and Wellness Centers located in the State of Michigan, current owners of an operating medical marijuana dispensary since January of this year. The discussions with UMED involve terms based around Easton Pharmaceuticals opening one or possibly more medical marijuana dispensary(s) in the State of Michigan with UMED being the manager of the operating business and facility. A counter proposal has been submitted to UMED where both companies would form a 50/50 joint partnership for new dispensaries with Easton paying the fees and expenses required to open the facilities and UMED finding the locations, design, launch the facilities, locate the product and patients for the dispensary. Discussions have also involved a direct investment into UMED for expansion of their existing business which after 6 months of operations with their own dispensary, revenues according to UMED are projected to conservatively reach $1 Million at the current pace with cumulative increases projected over the next few years. The new dispensaries in Michigan is thought of as an attractive opportunity to generate quick low overhead revenues for Easton due to costs that are deemed to be greatly reduced compared to the current costs required for its federal medical marijuana growers business in Canada as previously announced with MDRM Canada Group Inc. currently in its final inspection phase prior to receiving a Federal growers license for the entire country of Canada. The launch of dispensaries(s) in the state of Michigan does not presently require elaborate vaults or other expensive security systems as is required as per federal guidelines in Canada although dispensary's in Michigan are not legally allowed to grow their own product, but to only distribute medical marijuana to patients. Through consultations with advisors and other experts in the industry, with the ever improving sentiment to medical marijuana and to recreational use marijuana as is the case in the precedent setting, State of Colorado, eventually cross border or cross state importing and exporting of various strains of marijuana is believed to be approved. Easton Pharmaceuticals believes now would be the opportune time to get involved in the State of Michigan for Medical Marijuana before new rules are expected to come into effect resulting in more strict licensing requirements, security and other facets which would greatly increase the costs which as of the moment are a fraction compared to Canada's highly regulated, but extremely profitable industry or of that in other states such as Colorado and others.

In addition to the Michigan medical marijuana initiative, Easton has been presented with an opportunity to invest in a private company, soon to go public, to help fund a leading technology designed to ensure that cultivation, bottling, edible, extract manufacturers and dispensaries all maintain the highest food quality safety standards for antimicrobial and bacteria free facilities. In the wake of Colorado recently sending health inspectors to numerous facilities where large harvests were ordered destroyed and or recalled which was the same for large growers in Canada, this technology could save industry companies hundreds of thousands of dollars in lost revenue and brand damage. Colorado has announced new health standards and bacteria testing procedures will be coming into place by October. Other states will soon follow which is why an opportunity does exist and where Easton may conclude a deal next week.

A decision on both of the proposals and opportunities are expected to be made in the next week to 10 days and neither requires a large investment by Easton which would not impede or limit the closing of its recently announced MDRM Canada Group agreement where Easton has an exclusive option to purchase up to 49% in a private medical marijuana company who are in receipt of a letter to build from health Canada and are in the final build out stage of its facilities prior to a final inspection and before a national MMPR growers license is granted.

In other news, Easton Pharmaceuticals is placing serious consideration to moving forward with filing a form 10 or an S1 with the Securities and Exchange Commission to become a reporting issuer and to graduate up to the OTCBB or the OTCQB exchange. The difference with being an SEC reporting company is that its financial statements would be audited by a US GAAP auditor and filed on the SEC's Edgar system. Currently, its financial statements are validated by an attorney and filed on the OTC Markets exchange (OTC: EAPH) which is considered close to the same level of transparency with financial statements filed with the SEC, being a reporting SEC filer would require 8K's and other filings to be submitted on a more timely basis for material transactions.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors including medical marijuana, that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues related towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company's gel formulation is thought to be an innovative and unique transdermal delivery system. Easton Pharmaceuticals' product "VIORRA" is an over-the-counter, topical daily use product and aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder); the world market for these female conditions and the medical marijuana industry is conservatively estimated to be in the billions.

For More Information Visit:
http://www.eastonpharmaceuticalsinc.com

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any proposals, initiatives or negotiations will result in what the company had originally intended. Any investment made into Easton Pharmaceuticals would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact:

Carla Pepe
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email:
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
An edge gateway is an essential piece of infrastructure for large scale cloud-based services. In his session at 17th Cloud Expo, Mikey Cohen, Manager, Edge Gateway at Netflix, detailed the purpose, benefits and use cases for an edge gateway to provide security, traffic management and cloud cross region resiliency. He discussed how a gateway can be used to enhance continuous deployment and help testing of new service versions and get service insights and more. Philosophical and architectural ap...
DXWorldEXPO LLC announced today that Telecom Reseller has been named "Media Sponsor" of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
By 2021, 500 million sensors are set to be deployed worldwide, nearly 40x as many as exist today. In order to scale fast and keep pace with industry growth, the team at Unacast turned to the public cloud to build the world's largest location data platform with optimal scalability, minimal DevOps, and maximum flexibility. Drawing from his experience with the Google Cloud Platform, VP of Engineering Andreas Heim will speak to the architecture of Unacast's platform and developer-focused processes.
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, will provide an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life ...
"I think DevOps is now a rambunctious teenager – it’s starting to get a mind of its own, wanting to get its own things but it still needs some adult supervision," explained Thomas Hooker, VP of marketing at CollabNet, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We are still a relatively small software house and we are focusing on certain industries like FinTech, med tech, energy and utilities. We help our customers with their digital transformation," noted Piotr Stawinski, Founder and CEO of EARP Integration, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Chris Matthieu is the President & CEO of Computes, inc. He brings 30 years of experience in development and launches of disruptive technologies to create new market opportunities as well as enhance enterprise product portfolios with emerging technologies. His most recent venture was Octoblu, a cross-protocol Internet of Things (IoT) mesh network platform, acquired by Citrix. Prior to co-founding Octoblu, Chris was founder of Nodester, an open-source Node.JS PaaS which was acquired by AppFog and ...
The Founder of NostaLab and a member of the Google Health Advisory Board, John is a unique combination of strategic thinker, marketer and entrepreneur. His career was built on the "science of advertising" combining strategy, creativity and marketing for industry-leading results. Combined with his ability to communicate complicated scientific concepts in a way that consumers and scientists alike can appreciate, John is a sought-after speaker for conferences on the forefront of healthcare science,...
"We focus on SAP workloads because they are among the most powerful but somewhat challenging workloads out there to take into public cloud," explained Swen Conrad, CEO of Ocean9, Inc., in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"The Striim platform is a full end-to-end streaming integration and analytics platform that is middleware that covers a lot of different use cases," explained Steve Wilkes, Founder and CTO at Striim, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...